Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (7)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
2022
-
Vogt-Koyanagi-Harada disease in Spain
European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554
2020
-
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 608-615
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2015
-
Specific association of IL17A genetic variants with panuveitis
British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570
2007
-
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
European Journal of Ophthalmology, Vol. 17, Núm. 2, pp. 183-190
1997
-
Computer-assisted system for the approach to etiological uveitis diagnosis
Investigative Ophthalmology and Visual Science, Vol. 38, Núm. 4